- Home
- IVDA vs LGVN Comparison
IVDA vs LGVN Comparison
Compare IVDA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- LGVN
- Stock Information
- Founded
- IVDA 2003
- LGVN 2014
- Country
- IVDA United States
- LGVN United States
- Employees
- IVDA N/A
- LGVN N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- IVDA Technology
- LGVN Health Care
- Exchange
- IVDA Nasdaq
- LGVN Nasdaq
- Market Cap
- IVDA 6.7M
- LGVN 23.4M
- IPO Year
- IVDA N/A
- LGVN 2021
- Fundamental
- Price
- IVDA $2.19
- LGVN $1.43
- Analyst Decision
- IVDA
- LGVN Strong Buy
- Analyst Count
- IVDA 0
- LGVN 3
- Target Price
- IVDA N/A
- LGVN $8.67
- AVG Volume (30 Days)
- IVDA 78.9K
- LGVN 711.7K
- Earning Date
- IVDA 08-13-2025
- LGVN 08-13-2025
- Dividend Yield
- IVDA N/A
- LGVN N/A
- EPS Growth
- IVDA N/A
- LGVN N/A
- EPS
- IVDA N/A
- LGVN N/A
- Revenue
- IVDA $7,148,449.00
- LGVN $2,225,000.00
- Revenue This Year
- IVDA $340.48
- LGVN N/A
- Revenue Next Year
- IVDA N/A
- LGVN $51.48
- P/E Ratio
- IVDA N/A
- LGVN N/A
- Revenue Growth
- IVDA 54.15
- LGVN 127.50
- 52 Week Low
- IVDA $1.27
- LGVN $1.14
- 52 Week High
- IVDA $8.05
- LGVN $4.94
- Technical
- Relative Strength Index (RSI)
- IVDA 51.25
- LGVN 59.84
- Support Level
- IVDA $1.76
- LGVN $1.27
- Resistance Level
- IVDA $2.44
- LGVN $1.40
- Average True Range (ATR)
- IVDA 0.18
- LGVN 0.11
- MACD
- IVDA 0.04
- LGVN 0.04
- Stochastic Oscillator
- IVDA 57.53
- LGVN 61.40
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.